SCHEMBL17675755

SCHEMBL17675755

CCCS(=O)(=O)NCc1ccc2c(c1)C(Cc1cccc(F)c1)NCCC2

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 4/20 0.50
ALKBH5 Q6P6C2 1/20 0.35
CYP3A4 P08684 1/20 0.35
GAA P10253 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
HTR6 P50406 2/20 0.34
OPRM1 P35372 1/20 0.34
GHSR Q92847 1/20 0.34
SLC22A1 O15245 1/20 0.33
PRCP P42785 1/20 0.33
KDM1A O60341 1/20 0.33
MEN1 O00255 1/20 0.33
ABL1 P00519 1/20 0.33
ALPL P05186 1/20 0.33
KMT2A Q03164 1/20 0.33
RIN1 Q13671 1/20 0.33
ADRB2 P07550 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17675764 0.94 SLC6A9 (0.42) SLC6A9ALKBH5GAAKDM4EMAPT
SCHEMBL13827788 0.91 SLC6A9 (0.51) SLC6A9CYP3A4GAAKDM4EMAPT
SCHEMBL13827328 0.90 SLC6A9 (0.61) SLC6A9CYP3A4GHSRSLC22A1PRCP
SCHEMBL13738306 0.89 SLC6A9 (0.39) SLC6A9ALKBH5GAAHTR6OPRM1
SCHEMBL13827388 0.85 SLC6A9 (0.51) SLC6A9CYP3A4GAAKDM4EMAPT
SCHEMBL17675761 0.85 SLC6A9 (0.53) SLC6A9CYP3A4
SCHEMBL13827790 0.84 SLC6A9 (0.42) SLC6A9CYP3A4GAAKDM4EMAPT
SCHEMBL13827331 0.83 SLC6A9 (0.52) SLC6A9KDM4EMAPTSLC22A1PRCP
SCHEMBL13827492 0.81 SLC6A9 (0.49) SLC6A9CYP3A4GAAKDM4EMAPT
SCHEMBL17675754 0.81 POLB (0.40) SLC6A9MAPTHTR6GHSRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9309200-B2 Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG (DE) 2016-04-12 US disclosed